Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)

Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)

Coronavirus

90 Minutes

English Site

Recorded Webinar

Online

Course Overview

 

Remdesivir has emerged as a major treatment option for suspected or laboratory confirmed cases of COVID-19. Initial experience with remdesivir in patients with COVIDÔÇÉ19 emerged in the form of case reports and case series. However, there is a need for clinicians to continue to share their experience with each other. 

IMA-Karnataka welcomes doctors to this informative recorded session on "Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)"

During this event, our speakers were:

1. Dr. Vishnu Sharma, M.D. Tuberculosis and Respiratory Diseases , shared his experience on " Use of Remdesivir in treating patients with severe COVID-19, case presentations".
2. Dr. Ravindra Mehta, Chief of Critical Care, Consultant pulmonologist/Sleep Medicine Specialities, Apollo Hospitals, Bangalore, shared "Remdesivir in COVID19 - Current status and Practical Issues".

Moderator for this event was:

Dr. Somnath S.M, Consultant Physician, Sanjana Diabetes and Eye Care, Ballari.

Host Panelists were:

1. Dr. Madhusudana Kariganur, President, IMA Karnataka State
2. Dr. Srinivasa S.,Honorary State Secretary, IMA Karnataka

We wish you a great learning experience and thank IMA-Karnataka for hosting this session. We also thank our sponsors Mylan Pharmaceuticals Pvt. Ltd. to make this program possible. 


Trainers



Coming session Starts Oct 09, 2020
Ends Jan 09, 2021
IST